首页 › 基金 › JOHNSON & JOHNSON › NMRA
JOHNSON & JOHNSON 对 NMRA 的持仓历史
NEUMORA THERAPEUTICS INC. · 医疗保健
JOHNSON & JOHNSON 在 Q3 2026 的 13F 申报中披露持有 NMRA(NEUMORA THERAPEUTICS INC.)1,849,445 股,市值约 US$1.1M,约占其申报组合的 0.14%,在其申报持仓中市值排名第 12 位。 JOHNSON & JOHNSON 最近 13 个申报季度中有 13 个季度披露了 NMRA 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
JOHNSON & JOHNSON 对 NMRA 的持仓演变
JOHNSON & JOHNSON 于 Q3 2023 首次披露 NMRA 持仓:912,128 股(约 US$12.9M)。 该持仓在 Q4 2023 达到峰值 1,849,445 股,市值约 US$31.5M。 在 13 次申报中,JOHNSON & JOHNSON 1 次增持、0 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 1,849,445 股、市值约 US$1.1M。 持仓曾出现大幅变动:Q4 2023 增持约 103% (随后一个季度股价下跌 19%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 912.13K | $12.87M | 新进 |
| Q4 2023 | 1.85M | $31.53M | 增持 |
| Q1 2024 | 1.85M | $25.43M | 持有 |
| Q2 2024 | 1.85M | $18.18M | 持有 |
| Q3 2024 | 1.85M | $24.43M | 持有 |
| Q4 2024 | 1.85M | $19.60M | 持有 |
| Q1 2025 | 1.85M | $1.85M | 持有 |
| Q2 2025 | 1.85M | $1.40M | 持有 |
| Q3 2025 | 1.85M | $3.37M | 持有 |
| Q4 2025 | 1.85M | $3.31M | 持有 |
| Q1 2026 | 1.85M | $3.61M | 持有 |
| Q2 2026 | 1.85M | $3.14M | 持有 |
| Q3 2026 | 1.85M | $1.10M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NMRA 与 13F 数据
NMRA(NEUMORA THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 18 只申报持有 NMRA,申报仓位最大的包括:SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), ICONIQ Capital, LLC (US$4.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NMRA 的基金
- SOFTBANK GROUP CORP. 6.09M 股 · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M 股 · $7.58M · Q2 2026
- ICONIQ Capital, LLC 2.56M 股 · $4.35M · Q2 2026
- Boxer Capital Management, LLC 2.00M 股 · $3.40M · Q2 2026
- Exor N.V. 4.22M 股 · $2.51M · Q3 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M 股 · $1.97M · Q3 2026
更多关于 JOHNSON & JOHNSON
常见问题
How long has JOHNSON & JOHNSON held NMRA?
JOHNSON & JOHNSON has disclosed NMRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is JOHNSON & JOHNSON's current position in NMRA?
As of Q3 2026, JOHNSON & JOHNSON holds 1.85M shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $1.10M, representing 0.14% of its reported portfolio and ranking #12.
Has JOHNSON & JOHNSON been buying or selling NMRA?
In the latest 13F filing (Q3 2026), JOHNSON & JOHNSON held unchanged its position in NMRA. The position peaked in Q4 2023 at 1.85M shares.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, ICONIQ Capital, LLC, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.